Cargando…
Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy
The combined-immunotherapy of adoptive cell therapy (ACT) and cyclophosphamide (CTX) is one of the most efficient treatments for melanoma patients. However, no synergistic effects of CTX and ACT on the spatio-temporal dynamics of immunocytes in vivo have been described. Here, we visualized key cell...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173323/ https://www.ncbi.nlm.nih.gov/pubmed/27855783 http://dx.doi.org/10.7554/eLife.14756 |
_version_ | 1782484304415162368 |
---|---|
author | Qi, Shuhong Li, Hui Lu, Lisen Qi, Zhongyang Liu, Lei Chen, Lu Shen, Guanxin Fu, Ling Luo, Qingming Zhang, Zhihong |
author_facet | Qi, Shuhong Li, Hui Lu, Lisen Qi, Zhongyang Liu, Lei Chen, Lu Shen, Guanxin Fu, Ling Luo, Qingming Zhang, Zhihong |
author_sort | Qi, Shuhong |
collection | PubMed |
description | The combined-immunotherapy of adoptive cell therapy (ACT) and cyclophosphamide (CTX) is one of the most efficient treatments for melanoma patients. However, no synergistic effects of CTX and ACT on the spatio-temporal dynamics of immunocytes in vivo have been described. Here, we visualized key cell events in immunotherapy-elicited immunoreactions in a multicolor-coded tumor microenvironment, and then established an optimal strategy of metronomic combined-immunotherapy to enhance anti-tumor efficacy. Intravital imaging data indicated that regulatory T cells formed an 'immunosuppressive ring' around a solid tumor. The CTX-ACT combined-treatment elicited synergistic immunoreactions in tumor areas, which included relieving the immune suppression, triggering the transient activation of endogenous tumor-infiltrating immunocytes, increasing the accumulation of adoptive cytotoxic T lymphocytes, and accelerating the infiltration of dendritic cells. These insights into the spatio-temporal dynamics of immunocytes are beneficial for optimizing immunotherapy and provide new approaches for elucidating the mechanisms underlying the involvement of immunocytes in cancer immunotherapy. DOI: http://dx.doi.org/10.7554/eLife.14756.001 |
format | Online Article Text |
id | pubmed-5173323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-51733232016-12-23 Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy Qi, Shuhong Li, Hui Lu, Lisen Qi, Zhongyang Liu, Lei Chen, Lu Shen, Guanxin Fu, Ling Luo, Qingming Zhang, Zhihong eLife Cancer Biology The combined-immunotherapy of adoptive cell therapy (ACT) and cyclophosphamide (CTX) is one of the most efficient treatments for melanoma patients. However, no synergistic effects of CTX and ACT on the spatio-temporal dynamics of immunocytes in vivo have been described. Here, we visualized key cell events in immunotherapy-elicited immunoreactions in a multicolor-coded tumor microenvironment, and then established an optimal strategy of metronomic combined-immunotherapy to enhance anti-tumor efficacy. Intravital imaging data indicated that regulatory T cells formed an 'immunosuppressive ring' around a solid tumor. The CTX-ACT combined-treatment elicited synergistic immunoreactions in tumor areas, which included relieving the immune suppression, triggering the transient activation of endogenous tumor-infiltrating immunocytes, increasing the accumulation of adoptive cytotoxic T lymphocytes, and accelerating the infiltration of dendritic cells. These insights into the spatio-temporal dynamics of immunocytes are beneficial for optimizing immunotherapy and provide new approaches for elucidating the mechanisms underlying the involvement of immunocytes in cancer immunotherapy. DOI: http://dx.doi.org/10.7554/eLife.14756.001 eLife Sciences Publications, Ltd 2016-11-18 /pmc/articles/PMC5173323/ /pubmed/27855783 http://dx.doi.org/10.7554/eLife.14756 Text en © 2016, Qi et al http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Cancer Biology Qi, Shuhong Li, Hui Lu, Lisen Qi, Zhongyang Liu, Lei Chen, Lu Shen, Guanxin Fu, Ling Luo, Qingming Zhang, Zhihong Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy |
title | Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy |
title_full | Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy |
title_fullStr | Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy |
title_full_unstemmed | Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy |
title_short | Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy |
title_sort | long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy |
topic | Cancer Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173323/ https://www.ncbi.nlm.nih.gov/pubmed/27855783 http://dx.doi.org/10.7554/eLife.14756 |
work_keys_str_mv | AT qishuhong longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy AT lihui longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy AT lulisen longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy AT qizhongyang longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy AT liulei longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy AT chenlu longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy AT shenguanxin longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy AT fuling longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy AT luoqingming longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy AT zhangzhihong longtermintravitalimagingofthemulticolorcodedtumormicroenvironmentduringcombinationimmunotherapy |